In other cancers, for example, oestrogen receptor-positive breast cancer, high expression of IKKα is associated with reduced time to recurrence and reduced cancer-specific survival [3], low expression is an independent predictive biomarker for lower recurrence on sequential therapy [4]. Here, CHUK is linked to cancer.